Bone Disease

All articles by Bone Disease

FDA grants approval to Ipsen for ultra-rare bone disease drug

Jack O'Brien

August 17, 2023

11:01 am

Ipsen heralded the greenlight of the treatment, which reduces new, abnormal bone formation in soft and connective tissues for people living with FOP.

From Our Partners

Partner Content

How AI and first-party data is transforming pharma customer engagement

Using technology to improve audience segmentation, targeting and virtual interaction.

Partner Content

The importance of female representation in health

How to effect change and close the gender gap in healthcare.

Partner Content

The A100 Playbook Podcast | Real Chemistry: Visualizing the future: Art, science and AI innovation

Listen to Jack O’Brien of MM+M and Brandon Pletsch, president of scientific visualization at Real Chemistry, as they delve into the dynamic intersection of art, science and AI innovation in the field of scientific visualization.

Partner Content

Garbage in, garbage out — How health marketers can ensure the right information reaches patients and HCPs

This session with Justin Freid, chief marketing and innovation officer of CMI Media Group, and Daniel Nadler, founder of Open Evidence, will enlighten health brands to the possibilities of AI.

HAYMARKET MARKETING COMMUNICATIONS:

HAYMARKET MARKETING COMMUNICATIONS:

Quick Links

Bone Disease

All articles by Bone Disease

FDA grants approval to Ipsen for ultra-rare bone disease drug

AI Deciphered: Discovering the Potential for Marketers and Communicators

From Our Partners

Partner Content

How AI and first-party data is transforming pharma customer engagement

Partner Content

The importance of female representation in health

Partner Content

The A100 Playbook Podcast | Real Chemistry: Visualizing the future: Art, science and AI innovation

Partner Content

Garbage in, garbage out — How health marketers can ensure the right information reaches patients and HCPs